Portfolio Alerts Watch List Cart

Pharmaceutical

Refine Search

Product Compare (0)
S
Suven Life Sciences Ltd
Score 68/100• Decent
Suven Life Sciences Ltd shows potential for growth, but faces challenges in valuation and execution risks.
Company’s Health49/100
Valuation 20/100 · PB 40.856
Technical Avoid
1M -5.734% 6M 61.016% 1Y 57.247%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#46
View details ➜
S
Solara Active Pharma Sciences Ltd
Score 68/100• Decent
Solara Active Pharma Sciences Ltd shows potential for growth, but faces challenges in profitability and market competition.
Company’s Health24/100
Valuation 60/100 · PB 2.436
Technical Avoid
1M -0.025% 6M 21.307% 1Y -22.581%
Confidence100%
Reasonable PB valuation
Weak ROEPromoter pledge present
#47
View details ➜
S
SMS Pharmaceuticals Ltd
Score 68/100• Decent
SMS Pharmaceuticals Ltd shows decent potential with consistent growth, but faces challenges in valuation and liquidity.
Company’s Health66/100
Valuation 40/100 · PB 4.1828
Technical Momentum
1M 16.863% 6M 19.361% 1Y -2.975%
Confidence100%
Low leverage (D/E)
Weak ROEPromoter pledge present
#48
View details ➜
S
Shukra Pharmaceuticals Ltd
Score 68/100• Decent
Shukra Pharmaceuticals Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
Company’s Health89/100
Valuation 20/100 · PB 28.5764
Technical Momentum
1M 19.033% 6M 169.803% 1Y 480.467%
Confidence100%
Low leverage (D/E)No promoter pledge
#49
View details ➜
S
Shelter Pharma Ltd
Score 68/100• Decent
Shelter Pharma Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised.
Company’s Health84/100
Valuation 80/100 · PB 1.4518
Technical Avoid
1M -3.552% 6M 8.39% 1Y -29.688%
Confidence100%
Low leverage (D/E)No promoter pledge
#50
View details ➜
S
Samrat Pharmachem Ltd
Score 68/100• Decent
Samrat Pharmachem Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
Company’s Health75/100
Valuation 80/100 · PB 1.2516
Technical Avoid
1M -2.475% 6M -18.938% 1Y -38.948%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#51
View details ➜
R
Rainbow Children's Medicare Ltd
Score 68/100• Decent
Rainbow Children's Medicare Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health92/100
Valuation 20/100 · PB 9.4288
Technical Avoid
1M 2.556% 6M 0.676% 1Y -15.165%
Confidence100%
No promoter pledgeHealthy profit margins
#52
View details ➜
P
Panacea Biotec Ltd
Score 68/100• Decent
Panacea Biotec Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health55/100
Valuation 40/100 · PB 3.2014
Technical Avoid
1M 8.064% 6M -19.592% 1Y 32.116%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#53
View details ➜
M
Mankind Pharma Ltd
Score 68/100• Decent
Mankind Pharma Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
Company’s Health97/100
Valuation 20/100 · PB 6.7546
Technical Avoid
1M 0.613% 6M -0.075% 1Y -10.623%
Confidence100%
No promoter pledgeHealthy profit margins
#54
View details ➜
I
Indraprastha Medical Corporation Ltd
Score 68/100• Decent
Indraprastha Medical Corporation Ltd shows potential but faces challenges in growth consistency and profitability metrics. Caution is advised.
Company’s Health82/100
Valuation 20/100 · PB 9.3174
Technical Momentum
1M 31.812% 6M 53.863% 1Y 49.115%
Confidence100%
Low leverage (D/E)No promoter pledge
#55
View details ➜
E
Emcure Pharmaceuticals Ltd
Score 68/100• Decent
Emcure Pharmaceuticals shows potential for growth, but faces several challenges that could impact its performance.
Company’s Health85/100
Valuation 20/100 · PB 5.3865
Technical Watch
1M 6.183% 6M 29.266% 1Y -8.352%
Confidence100%
Low leverage (D/E)Decent revenue growth
Promoter pledge present
#56
View details ➜
P
PREVEST DENPRO LTD
Score 68/100• Decent
The stock shows potential but faces challenges in growth consistency and valuation metrics.
Company’s Health98/100
Valuation 20/100 · PB 5.9628
Technical Avoid
1M -1.933% 6M 12.026% 1Y -4.991%
Confidence100%
Low leverage (D/E)No promoter pledge
#57
View details ➜
P
Parnax Lab Ltd
Score 68/100• Decent
Parnax Lab Ltd shows potential in a growing sector but faces significant challenges in growth consistency and profitability metrics.
Company’s Health63/100
Valuation 80/100 · PB 1.78
Technical Avoid
1M -4.853% 6M 40.217% 1Y -11.432%
Confidence100%
Reasonable PB valuation
Promoter pledge presentThin margins
#58
View details ➜
O
Omkar Pharmachem Ltd
Score 68/100• Decent
Omkar Pharmachem Ltd shows potential but faces several challenges that may hinder growth.
Company’s Health68/100
Valuation 60/100 · PB 2.9998
Technical Avoid
1M 4.775% 6M -6.5% 1Y 0.972%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#59
View details ➜
M
Medicamen Organics Ltd
Score 68/100• Decent
Medicamen Organics Ltd shows potential for growth but faces several challenges that could impact its performance.
Company’s Health94/100
Valuation 80/100 · PB 1.2821
Technical Watch
1M 5.714% 6M 20.144% 1Y -38.148%
Confidence100%
Low leverage (D/E)No promoter pledge
#60
View details ➜
Showing 46 to 60 of 260 (18 Pages)